In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

Close

logo

English
  • Svenska
  • About us
    About us
      • This is Calliditas
      • Vision and Strategy
      • Board of Directors
      • Management Team
      • Corporate Responsibility
      • Our History
  • Disease overview
    Disease overview
      • IgA nephropathy
      • Nefecon
      • Orphan drugs
      • Scientific Advisory Board
  • Governance
    Governance
      • Corporate Governance Reports
      • Corporate Structure
      • General Meeting
        • General meetings
      • Nomination Committee
        • Nomination committees
      • Board and Committees
        • Board of Directors
        • Board fees
        • Work of the Board of Directors
        • Committees
      • Management
        • Management team
      • Remuneration
      • Internal control and risk management
      • Auditor
      • Articles of Association
  • Investors
    Investors
      • Share issue 2019
      • Capital Markets Day 2019
      • The share
        • Trading information
        • Ownership structure
        • Share capital development
        • Dividend policy
        • Analyst coverage
      • Financial Reports and Presentations
      • Prospectus
      • Press releases
      • Calendar
      • Subscribe
      • Contacts
  • Media
    Media
      • Press releases
      • Calliditas in Media
      • Subscribe
      • Contacts
  • Contacts
    Contacts
      • Offices
      • Partnering
      • Investors
      • Media
      • Career
  • Svenska

Calendar

2019
  • Upcoming events
  • 2020
  • 2019
  • 2018
Add to calendar
Feb 7, 2019

Year-end report for the period January 1 – December 31, 2018

Mar 5, 2019

Calliditas presenting at Carnegie Nordic Healthcare Seminar

Mar 13, 2019

The Stockholm Corporate Finance 11th Life Science Seminar

Mar 13, 2019

The Cowen and Company 39th Annual Health Care Conference in Boston, MA

Mar 27, 2019

The Stifel Nordic Healthcare Seminar, London

Apr 9, 2019 - Apr 10, 2019

Needham Healthcare Conference in NY

Apr 17, 2019

Kempen Life Sciences Conference, Amsterdam

May 8, 2019

Interim report for the period January 1 – March 31, 2019

May 8, 2019

Annual general meeting 2019

Jun 10, 2019

Redeye Growth Day

Aug 15, 2019

Interim report for the period 1 January – 30 June 2019

Sep 5, 2019

Pareto Securities Healthcare Conference

Nov 4, 2019

Capital Markets Day 2019

Nov 14, 2019

Interim report for the period 1 January – 30 September 2019

  • Investors
    • Capital Markets Day 2019
    • The share
      • Trading information
      • Ownership structure
      • Share capital development
      • Dividend policy
      • Analyst coverage
    • Financial Reports and Presentations
    • Prospectus
    • Press releases
    • Calendar
    • Subscribe
    • Contacts

Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Sweden

Company number: 556659-9766

  • Privacy policy
  • About cookies

© Calliditas Therapeutics AB 2019